PICTET ASSET MANAGEMENT LTD - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 82 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
PICTET ASSET MANAGEMENT LTD ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2021$65,591,000
-3.5%
745,696
+6.6%
0.07%
-13.4%
Q1 2021$67,987,000
-34.2%
699,235
-24.2%
0.08%
-39.3%
Q4 2020$103,388,000
+14.3%
921,869
-5.5%
0.14%
-4.9%
Q3 2020$90,475,000
+665.8%
975,994
+561.8%
0.14%
+576.2%
Q4 2019$11,815,000
-84.7%
147,480
-86.0%
0.02%
-74.1%
Q3 2019$77,288,000
+77.6%
1,051,964
+128.0%
0.08%
-13.8%
Q2 2019$43,529,000
-5.3%
461,450
-19.6%
0.09%
-6.9%
Q1 2019$45,972,000
+12.3%
574,288
-24.4%
0.10%
-1.9%
Q4 2018$40,953,000
-31.4%
759,655
-0.7%
0.10%
-18.3%
Q3 2018$59,690,000
+27.5%
764,664
+3.7%
0.13%
+12.5%
Q2 2018$46,819,000
-7.6%
737,538
+33.5%
0.11%
-10.4%
Q1 2018$50,669,000
+10.9%
552,554
-8.8%
0.12%
+5.9%
Q4 2017$45,694,000
+8.6%
605,944
+0.3%
0.12%
-0.8%
Q3 2017$42,077,000
+295.6%
603,942
+103.7%
0.12%
+260.6%
Q2 2017$10,636,000
-25.9%
296,438
-17.4%
0.03%
-29.8%
Q1 2017$14,351,000
+30.8%
358,866
-8.3%
0.05%
+14.6%
Q4 2016$10,972,000
+10.5%
391,173
+17.0%
0.04%
+10.8%
Q3 2016$9,928,000
+1755.7%
334,260
+1087.4%
0.04%
+1750.0%
Q2 2016$535,00028,1510.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2016
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders